The concentration ratio of Aβ42 to Aβ40 (Aβ42/40 ratio), the concentration of Aβ42 level and positive amyloid, and tau PET scan are considered as important biomarkers to detect AD (Hansson et al., 2019). This evidence concerns the gene MAPT and Alzheimer disease.